Skip to content

SI-BONE, Inc. SIBN Other Commercial Liabilities

Other Commercial Liabilities at other companies

Globus Medical logo
Globus MedicalGMED
IAR
Integra LifeSciencesIART
Carlsmed, Inc. Common Stock logo
Carlsmed, Inc. Common StockCARL
Bioventus logo
BioventusBVS
3D Systems logo
3D SystemsDDD
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s other commercial liabilities?
SI-BONE, Inc. (SIBN) reported other commercial liabilities of $14.07M in Q1 2026.
How has SI-BONE, Inc.'s other commercial liabilities changed year-over-year?
SI-BONE, Inc.'s other commercial liabilities decreased by 7.2% year-over-year, from $15.16M to $14.07M.
What is the long-term trend for SI-BONE, Inc.'s other commercial liabilities?
Over 5 years (2020 to 2025), SI-BONE, Inc.'s other commercial liabilities has grown at a 14.9% compound annual growth rate (CAGR), from $9.85M to $19.7M.